Endoscopic calcium treatment for stomach cancer bleeding
Part of Cancer, Digestive system clinical trials.
This trial tests a new endoscopic treatment that uses calcium and electric pulses to help stop bleeding from stomach tumors. It may be an option if you have bleeding or anemia from your stomach cancer and standard treatments are not suitable or not working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed diagnosis of stomach cancer.
- You must have anemia or bleeding from the stomach cancer.
- You must be either not able to have standard cancer treatments (surgery or chemo), or you are receiving treatment for advanced cancer, or you are getting treatment before surgery and have bleeding that interrupts it, or you have declined standard treatment.
- You cannot have certain medical devices like a pacemaker that can't be safely turned off during the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new approach that combines freezing the tumor from inside the stomach with an immunotherapy drug that helps your immune system fight cancer. It is for people with advanced stomach cancer that has not responded to previous chemotherapy.
This trial tests a combination of low-dose radiation, chemotherapy, and an immunotherapy drug (AK112) for people with advanced stomach or gastroesophageal junction cancer that has progressed after first-line treatment. The goal is to see if this combination can help shrink tumors or slow the cancer's growth.
This study looks at using a blood test that finds tiny bits of cancer DNA to decide if you need extra chemotherapy after surgery. It aims to make treatment more personalized and reduce side effects for people with locally advanced stomach cancer.
This trial tests a technique called full-time RDI during ESD (a minimally invasive procedure to remove early stomach cancer). The goal is to see if it can lower the chance of serious side effects and shorten the procedure time. If you are scheduled for this surgery and meet the health requirements, you may be able to join.
This trial is testing whether using a blood test to find tiny amounts of cancer DNA after initial treatment can guide decisions about further therapy for people with stomach cancer. The goal is to personalize follow-up treatment to reduce the chance of cancer returning.
This trial studies blood-based biomarkers to help doctors choose the best individualized surgical treatment for gastroesophageal junction adenocarcinoma. If you qualify, you’ll get standard care plus additional testing to see whether the blood results can guide surgery more precisely.
Hear when a new Calcium Electroporation for Hemostasis in Gastric Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.